A cannabinoids company backed by David Beckham become the first company of its kind to formally unveil plans for a main London stock market debut.

Cellular Goods, a UK-based provider of premium consumer products based on biosynthetic cannabinoids.

With the legal cannabis industry set to be the next true growth market, and estimated to be worth £2.31 billion by 2024, businesses and investors are in a prime position to capitalise on this first-mover advantage.

Cellular Goods is the first provider of premium consumer products based on biosynthetic cannabinoids to join the London stock market.

The company, which is run by Alexis Abraham, has sold a minority stake to DB Ventures, the former Manchester United and England midfielder’s global brand management and commercial ventures arm, according to people close to the situation.

https://www.share-talk.com/alexia-blake-head-of-research-product-development-cellular-goods-cbx-l-interview/